Compile Data Set for Download or QSAR
Report error Found 545 Enz. Inhib. hit(s) with all data for entry = 10715
TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561513(US11390631, Example 54 | US12268694, Example 54)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561511(US11390631, Example 52 | US12268694, Example 52)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561514(US11390631, Example 55 | US12268694, Example 55)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561860(US11390631, Example 403 | Step c)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561864(US11390631, Example 407 | Step d)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561849(US11390631, Example 387 | Step b)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561850(US11390631, Example 388 | US12268694, Example 388)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561886(US11390631, Example 429 | US12268694, Example 429)
Affinity DataEC50: <400nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561575(US11390631, Example 115 | US12268694, Example 115)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561580(US11390631, Example 120 | US12268694, Example 120)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561601(US11390631, Example 138)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561602(US11390631, Example 139 | US12268694, Example 139)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561599(US11390631, Example 136 | Step j)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561606(US11390631, Example 143 | US12268694, Example 143)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561603(US11390631, Example 140 | US12268694, Example 140)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561607(US11390631, Example 144 | Step a)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561612(US11390631, Example 149 | US11390631, Example 150)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561614(US11390631, Example 151 | Step d)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561586(US11390631, Example 125a | US12268694, Example 125...)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561583(US11390631, Example 123 | US12268694, Example 123)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561584(US11390631, Example 124a | US11390631, Example 124)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561590(US11390631, Example 127 | Step b | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561588(US11390631, Example 126a | US12268694, Example 126...)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561594(US11390631, Example 131 | US12268694, Example 131)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561592(US11390631, Example 129 | US12268694, Example 129)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561595(US11390631, Example 132 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561631(US11390631, Example 168 | US12268694, Example 168)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561632(US11390631, Example 169 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561637(US11390631, Example 174 | Step c)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561638(US11390631, Example 175 | Step a)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561642(US11390631, Example 179 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561639(US11390631, Example 176 | US12268694, Example 176)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561645(US11390631, Example 182 | Step a)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561646(US11390631, Example 183 | US12268694, Example 183)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561643(US11390631, Example 180 | US11390631, Example 404 ...)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561644(US11390631, Example 181 | Step b | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561617(US11390631, Example 154 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561618(US11390631, Example 155 | Step c)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561615(US11390631, Example 152 | Step d)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561616(US11390631, Example 153 | Step a)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561621(US11390631, Example 158 | Step c | US12268694, Exa...)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561622(US11390631, Example 159 | Step a)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561620(US11390631, Example 157 | US12268694, Example 157)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561625(US11390631, Example 162 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561623(US11390631, Example 160 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561630(US11390631, Example 167 | Step b)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561627(US11390631, Example 164 | Step c)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561705(US11390631, Example 242 | US12268694, Example 242)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561708(US11390631, Example 245 | Step a)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

TargetGag-Pol polyprotein(ALV-A RSA)
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM561694(US11390631, Example 231 | US12268694, Example 231)
Affinity DataEC50: <400nMAssay Description:The description is Japanese.More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2022
Entry Details
US Patent

Displayed 1 to 50 (of 545 total ) | Next | Last >>
Jump to: